US Patent Application No: 2005/0277,129

Number of patents in Portfolio can not be more than 2000

APOE genetic markers associated with age of onset of Alzheimer's disease

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Haplotypes in the APOE gene associated with age of onset of Alzheimer's Disease are disclosed. Compositions and methods for detecting and using these APOE haplotypes in a variety of clinical applications are disclosed. Such applications include articles of manufacture comprising compounds effective in delaying the age of onset of AD in individuals at risk for developing AD and having one of these APOE haplotypes, methods and kits for predicting the age of onset of AD in an individual at risk for developing AD based upon his/her haplotype profile, and methods for delaying the age of onset of AD in individuals at risk for developing AD based upon their haplotype profile.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
PGXHEALTH, LLCNEWTON, MA15

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aerssens, Jeroen Nieuwrode, BE 18 16
Athanasiou, Maria Derby, CT 19 5
Brain, Carlos Somerville, MA 15 5
Cohen, Nadine Warren, NJ 18 16
Dain, Bradley Hamden, CT 15 5
Denton, R Rex Madison, CT 22 18
Judson, Richard S Guilford, CT 25 79
Ozdemir, Vural Long Beach, CA 14 4
Reed, Carol R Bethany, CT 15 5

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
ZINFANDEL PHARMACEUTICALS, INC. (2)
8,815,508 Method of identifying disease risk factors 0 2009
8,846,315 Disease risk factors and methods of use 0 2011